Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Keyphrases
Lymphoma
100%
AIDS/HIV
100%
Molecular Pathology
100%
Diffuse Large B-cell Lymphoma (DLBCL)
30%
Cell Lymphoma
30%
Genetic Lesions
20%
B Cells
20%
Histological Subtypes
20%
Presentation Time
20%
Tumor
10%
Host Factors
10%
Clinical Features
10%
BCL6
10%
C-Myc
10%
Non-Hodgkin Lymphoma
10%
Epstein-Barr Virus
10%
Epstein-Barr Virus Infections
10%
Cytokine Production
10%
Lymphomagenesis
10%
Clinical Outcomes
10%
Molecular Pathways
10%
Age of Onset
10%
Cell Population
10%
HIV Infection
10%
Infected Individual
10%
CD4 Count
10%
Genetic Pathways
10%
6q Deletion
10%
Intermediate Grade
10%
P53 Inactivation
10%
Generalized Lymphadenopathy
10%
Immunosurveillance
10%
Time Elapsed
10%
Chronic Antigenic Stimulation
10%
Working Formulation
10%
RAS mutation
10%
Oligoclonal Expansion
10%
Clinical Phase
10%
Infection Outcomes
10%
Immunology and Microbiology
Acquired Immune Deficiency Syndrome
100%
Lymphoma Cell
66%
B Cell
22%
Epstein Barr Virus
22%
Host Factor
11%
P53
11%
Human Immunodeficiency Virus
11%
Cytokine Production
11%
Human Immunodeficiency Virus Infection
11%
Immunostimulation
11%
Infectious Disease
11%
Cell Population
11%
Immunosurveillance
11%
Lymphadenopathy
11%
CD4 Lymphocyte Count
11%
Infection
11%
Virus Infection
11%
Veterinary Science and Veterinary Medicine
Acquired Immune Deficiency Syndrome
100%
B Cell
22%
Epstein-Barr Virus
22%
P53
11%
CD4
11%
Human Immunodeficiency Virus Infection
11%
Non-Hodgkin Lymphoma
11%
Virus Infection
11%
Tumor
11%
Infectious Disease
11%